FDA Intelligence | FDA

Advertising and Promotion

Sep 8, 2019
Opioid Settlements Raise Questions for Future Off-label Marketing Cases
Aug 5, 2019
2019 OPDP Enforcement Letters Highlight Agency Concern About Risk Minimization
Jul 6, 2019
OPDP Enforcement Emphasizing Risk Minimization
Jun 8, 2019
Recent Untitled Letter Offers Blueprint for Handling Risk/Safety Disclosures in Promotions
May 6, 2019
Consumer Education Needed on DTC Ad Info
Apr 6, 2019
New Era of Drug Promotion Dawns
Mar 11, 2019
Gottlieb Will Be a Tough Act To Follow
Nov 27, 2018
NEJM Perspective Article Questions DTC Pricing Proposal
Nov 12, 2018
‘Bad Ad’ Program Is Alive and Well
Oct 24, 2018
What Companies Can Do About Competitor’s ‘Bad Ads’

Good Clinical Practice

Food Labeling

FDA Regulation & Enforcement

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.